Development of Monoclonal Gammopathy of Undetermined Significance after Kidney Transplant
Jin-Lan Tan(Guy's and St Thomas' NHS Foundation Trust), Matthew Streetly(King's College - North Carolina), Inas El‐Najjar(Guy's and St Thomas' NHS Foundation Trust), Gillian R. Milner(University of Cape Town), Stephen Schey(University College Hospital), M. Kazmi(St Thomas' Hospital), T. Dorling(Guy's and St Thomas' NHS Foundation Trust)
Cited by 0
Related Papers
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation
|Blood|2000|502
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
|Blood|2018|421
Phase I Study of an Immunomodulatory Thalidomide Analog, CC-4047, in Relapsed or Refractory Multiple Myeloma
|Journal of Clinical Oncology|2004|315